Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 29 of Aligos Therapeutics, Inc.'s SEC filings and found 4 warrant series and 3 shelf registrations on file for ALGS. The latest dilution event on file is a registration statement on Apr 3, 2025. Analysis updated Oct 7, 2026.
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z
NXTCNextCure, Inc.
ABVCABVC BioPharma, Inc.
MBAIMBody AI Ltd.
BCTXBriaCell Therapeutics Corp.
AARDAardvark Therapeutics, Inc. Common Stock
FLNAFilana Therapeutics, Inc.
BYSIBeyondSpring Inc.
EVAXEvaxion A/S American Depositary Share
RNAZTransCode Therapeutics, Inc.
PLRZPolyrizon Ltd. Ordinary Shares
CELUCelularity Inc.
MGXMetagenomi, Inc. Common Stock
CRVOCervoMed Inc.
CVMCEL-SCI Corporation
ACETAdicet Bio, Inc.